fms-Like Tyrosine Kinase 3, antagonists & inhibitors
- Name
- fms-Like Tyrosine Kinase 3, antagonists & inhibitors
- Accession Number
- DBCAT002780
- Description
Not Available
- Drugs
Drug Drug Description SB-1578 SB-1578 is under investigation in clinical trial NCT01235871 (A Single and Multiple-Dose Study of SB1578). Gilteritinib An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. - Drugs & Drug Targets